Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
2 Stocks That Could Surprise Investors in 2023
05:10am, Thursday, 01'st Dec 2022
Investing in safe healthcare stocks may be an underrated strategy to deploy.
AstraZeneca (AZN) Boosts Cell Therapies With Neogene Deal
09:47am, Wednesday, 30'th Nov 2022
The acquisition of Neogene is set to give AstraZeneca (AZN) access to the latter's next-generation T-cell receptor therapies.
AstraZeneca sells Ohio manufacturing plant to National Resilience
04:06am, Wednesday, 30'th Nov 2022
AstraZeneca PLC (LSE:AZN) said it has sold its manufacturing site in West Chester, Ohio to National Resilience, Inc., which plans to expand the site and support future growth of its medicines manufact
AstraZeneca adds focus on personalised cancer cell therapy with US$320mln acquisition
03:35am, Tuesday, 29'th Nov 2022
AstraZeneca PLC (LSE:AZN) will spend up to US$320mln to strengthen its cancer business with an acquisition specialising in an innovative cell therapy approach for hard-to-treat cancers. Amsterdam-base
C4X Discovery signs exclusive global licence with AstraZeneca
03:20am, Monday, 28'th Nov 2022
C4X Discovery Holdings PLC (AIM:C4XD) (C4XD) has signed an exclusive worldwide licensing agreement with AstraZeneca worth up to US$402mln, for developing and commercialising its NRF2 Activator program
Astrazeneca (AZN) is a Top-Ranked Value Stock: Should You Buy?
11:17am, Thursday, 24'th Nov 2022
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
AstraZeneca vaccine found to be 79% effective in U.S. study
09:46am, Saturday, 19'th Nov 2022
Dr. David Levy, CEO of EHE Health, joins Worldwide Exchange on the news that AstraZeneca's Covid-19 vaccine has been found to be 79% effective in a U.S. study.
2 Stocks to Buy Whether or Not a Recession Is Coming
09:37am, Friday, 18'th Nov 2022
Both have outperformed the stock market this year.
AstraZeneca's (AZN) 3 Cancer Drugs Get CHMP Nod for Expanded Use
11:18am, Tuesday, 15'th Nov 2022
The CHMP recommends expanded use of AstraZeneca's (AZN) three key cancer drugs, Lynparza, Enhertu and Imfinzi.
AstraZeneca's (AZN) Imfinzi/Imjudo Combo Gets Another FDA Nod
03:48pm, Monday, 14'th Nov 2022
AstraZeneca (AZN) gets its second FDA approval for the Imfinzi+Imjudo combo in non-small cell lung cancer (NSCLC) indication.
Why AstraZeneca Stock Shot Higher Today
06:30pm, Thursday, 10'th Nov 2022
The company trounced analyst profitability estimates for its latest quarter and raised its guidance.
AstraZeneca PLC (AZN) Q3 2022 Earnings Call Transcript
02:44pm, Thursday, 10'th Nov 2022
AstraZeneca PLC (NASDAQ:AZN ) Q3 2022 Earnings Conference Call November 10, 2022 6:45 AM ET Company Participants Andy Barnett - Head of Investor Relations Pascal Soriot - Executive Director and CEO Ar
AstraZeneca's (AZN) Q3 Earnings Beat, EPS Growth View Up
12:02pm, Thursday, 10'th Nov 2022
AstraZeneca (AZN) beats third-quarter estimates for earnings while sales come in line. AZN raises its 2022 earnings growth guidance, keeping its sales forecast unchanged.
AstraZeneca Makes A Break For A Buy Point On Massive Third-Quarter Growth
11:54am, Thursday, 10'th Nov 2022
AstraZeneca leaned on cancer drugs in the third-quarter, leading to double-digit sales growth, a strong beat and a jump for AZN stock. The post AstraZeneca Makes A Break For A Buy Point On Massive Thi
AstraZeneca Stock Surges on Upbeat Earnings, Forecast
11:25am, Thursday, 10'th Nov 2022
AstraZeneca PLC (NASDAQ:AZN) stock is up 7% at $65.30 at last glance, after the biotech name posted an upbeat third-quarter report and raised forecast.
